Non-specific cellular RNAs (RNA)

Non-specific cellular RNAs refer to the collective pool of ribonucleic acids within a cell, including mRNA, rRNA, tRNA, and various non-coding RNAs, rather than a single defined molecular entity. In a therapeutic context, this term often describes the broad, non-selective interaction of certain drugs with the cellular RNA machinery. For example, fluoropyrimidines like 5-fluorouracil (5-FU) are metabolized into ribonucleotides that incorporate into all classes of RNA, disrupting post-transcriptional processing and ribosome assembly [Longley DB, et al. (2003) Nat Rev Cancer; Burger K, et al. (2010) Nat Commun]. This broad mechanism is a hallmark of several classical cytotoxic chemotherapies, which exploit the high RNA synthesis rates in malignant cells but often suffer from significant off-target toxicities in healthy tissues [Silvera D, et al. (2010) Nat Rev Cancer]. Furthermore, non-specific RNA structures, particularly double-stranded RNA, can serve as ligands for innate immune sensors such as Toll-like receptors (TLRs) and RIG-I-like receptors, potentially leading to inflammatory responses [Kawai T, Akira S. (2010) Nat Immunol]. Consequently, while 'non-specific cellular RNAs' are technically targeted by various agents, modern drug development typically seeks to move away from such broad interactions toward sequence-specific or structure-specific RNA targeting to improve safety and efficacy [Warner JR. (1999) Trends Biochem Sci].

Other names

Total cellular RNABulk RNACytoplasmic RNANuclear RNARibonucleic acid

Broad incorporation into RNA species leading to defective processing and translation; non-specific binding to ribosomal subunits; activation of innate immune pattern recognition receptors.